- $2.74bn
- $4.60bn
- $3.79bn
- 49
- 71
- 14
- 42
Annual income statement for DENTSPLY SIRONA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K/A | 10-K/A | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3,339 | 4,231 | 3,922 | 3,965 | 3,793 |
| Cost of Revenue | |||||
| Gross Profit | 1,700 | 2,344 | 2,127 | 2,090 | 1,968 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 3,342 | 3,623 | 4,862 | 4,050 | 4,672 |
| Operating Profit | -3 | 608 | -940 | -85 | -879 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -50 | 545 | -1,055 | -175 | -936 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -73 | 411 | -950 | -132 | -910 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -73 | 411 | -950 | -132 | -910 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -73 | 411 | -950 | -132 | -910 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.497 | 1.93 | -0.475 | 0.546 | -0.931 |
| Dividends per Share |